Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.48 INR | -2.56% | -15.29% | -39.83% |
30/04 | Vivanza Biosciences Limited Announces Directors Resignation | CI |
30/04 | Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Business Summary
Number of employees: 5
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 104 | 100.0 % | 178 | 100.0 % | +71.22% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 104 | 100.0 % | 178 | 100.0 % | +71.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jaynedra Mehta
CEO | Chief Executive Officer | - | 25/23/25 |
Director of Finance/CFO | - | 17/16/17 | |
Avinash Bhojwani
CMP | Compliance Officer | - | 27/22/27 |
Director/Board Member | - | 29/19/29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 29/19/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,000,000 | 15,993,974 ( 39.98 %) | 0 | 39.98 % |
Company contact information
Vivanza Biosciences Ltd.
403/TF, Sarthik II Opposite Rajpath Club
380054, Ahmedabad
+91 79 2687 0952
http://www.vivanzabiosciences.comSector
1st Jan change | Capi. | |
---|---|---|
-39.83% | 3.19M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.34% | 239B | |
+6.68% | 204B | |
-9.08% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- VIVANZA6 Stock
- Company Vivanza Biosciences Limited